Open access · CC-BY
via OpenAlex
The leaky gut and the gut microbiome in sepsis – targets in research and treatment
Wiwat Chancharoenthana, Supitcha Kamolratanakul, Marcus Josephus Schultz, Asada Leelahavanichkul
Clinical Science · 2023 · ▲ 86 citations
Abstract
Both a leaky gut (a barrier defect of the intestinal surface) and gut dysbiosis (a change in the intestinal microbial population) are intrinsic to sepsis. While sepsis itself can cause dysbiosis, dysbiosis can worsen sepsis. The leaky gut syndrome refers to a status with which there is an increased intestinal permeability allowing the translocation of microbial molecules from the gut into the blood circulation. It is not just a symptom of gastrointestinal involvement, but also an underlying cause that develops independently, and its presence could be recognized by the detection, in blood, of lipopolysaccharides and (1→3)-β-D-glucan (major components of gut microbiota). Gut-dysbiosis is the consequence of a reduction in some bacterial species in the gut microbiome, as a consequence of intestinal mucosal immunity defect, caused by intestinal hypoperfusion, immune cell apoptosis, and a variety of enteric neuro-humoral-immunity responses. A reduction in bacteria that produce short-chain fatty acids could change the intestinal barriers, leading to the translocation of pathogen molecules, into the circulation where it causes systemic inflammation. Even gut fungi might be increased in human patients with sepsis, even though this has not been consistently observed in murine models of sepsis, probably because of the longer duration of sepsis and also antibiotic use in patients. The gut virobiome that partly consists of bacteriophages is also detectable in gut contents that might be different between sepsis and normal hosts. These alterations of gut dysbiosis altogether could be an interesting target for sepsis adjuvant therapies, e.g., by faecal transplantation or probiotic therapy. Here, current information on leaky gut and gut dysbiosis along with the potential biomarkers, new treatment strategies, and future research topics are mentioned.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1042/cs20220777
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Chancharoenthana, W., Kamolratanakul, S., Schultz, M.J., & Leelahavanichkul, A. (2023). The leaky gut and the gut microbiome in sepsis – targets in research and treatment. <em>Clinical Science</em>. https://doi.org/10.1042/cs20220777
Vancouver
Chancharoenthana W, Kamolratanakul S, Schultz MJ, Leelahavanichkul A. The leaky gut and the gut microbiome in sepsis – targets in research and treatment. Clinical Science. 2023. doi:10.1042/cs20220777.
BibTeX
@article{wiwat2023Thelea,
title = {The leaky gut and the gut microbiome in sepsis – targets in research and treatment},
author = {Wiwat Chancharoenthana and Supitcha Kamolratanakul and Marcus Josephus Schultz and Asada Leelahavanichkul},
journal = {Clinical Science},
year = {2023},
doi = {10.1042/cs20220777},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Communications 2021
Open access · CC-BY
Specific gut microbiome signatures and the associated pro-inflamatory functions are linked to pediatric allergy and acquisition of immune tolerance
Neural Regeneration Research 2024
Open access · CC-BY
Gut microbiota–astrocyte axis: new insights into age-related cognitive decline
Frontiers in Microbiology 2018
Open access · CC-BY
The Human Gut Microbiome – A Potential Controller of Wellness and Disease
Progress in molecular biology and translational science 2022
Citation only
Gut microbiome dysbiosis in neonatal sepsis
European Journal of Heart Failure 2020
Open access · OA
Gut Dysbiosis and Heart Failure: Navigating the Universe Within
Centre Hospitalier Universitaire de Besancon 2021
Open access · US-GOV